NO20033682D0 - Epothilone-derivater for behandling av refraktor-tumorer - Google Patents
Epothilone-derivater for behandling av refraktor-tumorerInfo
- Publication number
- NO20033682D0 NO20033682D0 NO20033682A NO20033682A NO20033682D0 NO 20033682 D0 NO20033682 D0 NO 20033682D0 NO 20033682 A NO20033682 A NO 20033682A NO 20033682 A NO20033682 A NO 20033682A NO 20033682 D0 NO20033682 D0 NO 20033682D0
- Authority
- NO
- Norway
- Prior art keywords
- treatment
- epothilone derivatives
- refractory tumors
- tumors
- refractory
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 150000003883 epothilone derivatives Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26985801P | 2001-02-20 | 2001-02-20 | |
PCT/US2002/004247 WO2002066033A1 (en) | 2001-02-20 | 2002-02-06 | Epothilone derivatives for the treatment of refractory tumors |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20033682D0 true NO20033682D0 (no) | 2003-08-19 |
NO20033682L NO20033682L (no) | 2003-08-19 |
Family
ID=23028941
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20033682A NO20033682L (no) | 2001-02-20 | 2003-08-19 | Epothilone-derivater for behandling av refraktor-tumorer |
Country Status (18)
Country | Link |
---|---|
US (1) | US6727276B2 (no) |
EP (1) | EP1368030A1 (no) |
JP (1) | JP2004522771A (no) |
KR (1) | KR20040028720A (no) |
CN (1) | CN1610549A (no) |
BG (1) | BG108072A (no) |
BR (1) | BR0207316A (no) |
CA (1) | CA2438598A1 (no) |
EE (1) | EE200300397A (no) |
HU (1) | HUP0400041A2 (no) |
IL (1) | IL157128A0 (no) |
IS (1) | IS6917A (no) |
MX (1) | MXPA03007423A (no) |
NO (1) | NO20033682L (no) |
PL (1) | PL363363A1 (no) |
RU (1) | RU2003128312A (no) |
WO (1) | WO2002066033A1 (no) |
ZA (1) | ZA200306237B (no) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6204388B1 (en) * | 1996-12-03 | 2001-03-20 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto and analogues thereof |
WO1999001124A1 (en) | 1996-12-03 | 1999-01-14 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
US20050043376A1 (en) * | 1996-12-03 | 2005-02-24 | Danishefsky Samuel J. | Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
US6780620B1 (en) * | 1998-12-23 | 2004-08-24 | Bristol-Myers Squibb Company | Microbial transformation method for the preparation of an epothilone |
US20020058286A1 (en) * | 1999-02-24 | 2002-05-16 | Danishefsky Samuel J. | Synthesis of epothilones, intermediates thereto and analogues thereof |
US7312237B2 (en) * | 2001-03-14 | 2007-12-25 | Bristol-Myers Squibb Co. | Combination of epothilone analogs and chemotherapeutic agents for the treatment of prolilferative diseases |
TW200403994A (en) * | 2002-04-04 | 2004-03-16 | Bristol Myers Squibb Co | Oral administration of EPOTHILONES |
TW200400191A (en) * | 2002-05-15 | 2004-01-01 | Bristol Myers Squibb Co | Pharmaceutical compositions and methods of using C-21 modified epothilone derivatives |
US7649006B2 (en) | 2002-08-23 | 2010-01-19 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto and analogues thereof |
US7384964B2 (en) * | 2002-08-23 | 2008-06-10 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
US6921769B2 (en) | 2002-08-23 | 2005-07-26 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto and analogues thereof |
WO2004018478A2 (en) | 2002-08-23 | 2004-03-04 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
JP2006504743A (ja) | 2002-10-09 | 2006-02-09 | コーザン バイオサイエンシス インコーポレイテッド | 治療製剤 |
US20050171167A1 (en) * | 2003-11-04 | 2005-08-04 | Haby Thomas A. | Process and formulation containing epothilones and analogs thereof |
US20050215604A1 (en) * | 2004-03-26 | 2005-09-29 | Kosan Biosciences, Inc. | Combination therapies with epothilones and carboplatin |
AR052142A1 (es) * | 2004-11-18 | 2007-03-07 | Bristol Myers Squibb Co | Perla recubierta enterica que comprende ixabepilona, y preparacion y administracion de la misma |
WO2006055742A1 (en) * | 2004-11-18 | 2006-05-26 | Bristol-Myers Squibb Company | Enteric coated bead comprising epothilone or epothilone analog, and preparation and administration thereof |
JP2008536479A (ja) | 2005-02-11 | 2008-09-11 | ユニバーシティ オブ サザン カリフォルニア | ジスルフィド架橋を有するタンパク質の発現法 |
CA2607940C (en) | 2005-05-18 | 2009-12-15 | Aegera Therapeutics Inc. | Bir domain binding compounds |
WO2007130501A2 (en) | 2006-05-01 | 2007-11-15 | University Of Southern California | Combination therapy for treatment of cancer |
BRPI0711591A2 (pt) | 2006-05-16 | 2011-11-16 | Aegera Therapeutics Inc | composto de ligação de domìnio bir da iap |
US8802394B2 (en) | 2008-11-13 | 2014-08-12 | Radu O. Minea | Method of expressing proteins with disulfide bridges with enhanced yields and activity |
SG182724A1 (en) | 2010-02-12 | 2012-08-30 | Pharmascience Inc | Iap bir domain binding compounds |
CA2799202C (en) | 2010-05-18 | 2016-07-05 | Cerulean Pharma Inc. | Compositions and methods for treatment of autoimmune and other diseases |
CN110105368B (zh) * | 2019-05-09 | 2022-01-07 | 上海大学 | 去氧紫杉烷类似物及其制备方法 |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4138042C2 (de) | 1991-11-19 | 1993-10-14 | Biotechnolog Forschung Gmbh | Epothilone, deren Herstellungsverfahren sowie diese Verbindungen enthaltende Mittel |
DE19639456A1 (de) | 1996-09-25 | 1998-03-26 | Biotechnolog Forschung Gmbh | Epothilon-Derivate, Herstellung und Mittel |
DE19542986A1 (de) | 1995-11-17 | 1997-05-22 | Biotechnolog Forschung Gmbh | Epothilon-Derivate und deren Verwendung |
ATE218556T1 (de) | 1995-11-17 | 2002-06-15 | Biotechnolog Forschung Gmbh | Epothilon-derivate und deren herstellung |
DE19645361A1 (de) | 1996-08-30 | 1998-04-30 | Ciba Geigy Ag | Zwischenprodukte innerhalb der Totalsynthese von Epothilon A und B, Teil II |
DE19645362A1 (de) | 1996-10-28 | 1998-04-30 | Ciba Geigy Ag | Verfahren zur Herstellung von Epothilon A und B und Derivaten |
US5969145A (en) * | 1996-08-30 | 1999-10-19 | Novartis Ag | Process for the production of epothilones and intermediate products within the process |
JP2001500851A (ja) | 1996-08-30 | 2001-01-23 | ノバルティス アクチエンゲゼルシャフト | エポシロンの製造法および製造過程中に得られる中間生産物 |
AU753546B2 (en) | 1996-11-18 | 2002-10-24 | Helmholtz-Zentrum Fuer Infektionsforschung Gmbh | Epothilone C, D, E and F, production process, and their use as cytostatic as well as phytosanitary agents |
US6515016B2 (en) | 1996-12-02 | 2003-02-04 | Angiotech Pharmaceuticals, Inc. | Composition and methods of paclitaxel for treating psoriasis |
WO1999001124A1 (en) | 1996-12-03 | 1999-01-14 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
US6204388B1 (en) | 1996-12-03 | 2001-03-20 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto and analogues thereof |
US6380394B1 (en) | 1996-12-13 | 2002-04-30 | The Scripps Research Institute | Epothilone analogs |
US6441186B1 (en) | 1996-12-13 | 2002-08-27 | The Scripps Research Institute | Epothilone analogs |
DE19701758A1 (de) | 1997-01-20 | 1998-07-23 | Wessjohann Ludgar A Dr | Epothilone-Synthesebausteine |
CN1544436A (zh) | 1997-02-25 | 2004-11-10 | ���\���о�����˾��GBF�� | 3,7-保护的环氧噻嗪酮-n-氧化物及其制备方法 |
DE19713970B4 (de) | 1997-04-04 | 2006-08-31 | R&D-Biopharmaceuticals Gmbh | Epothilone-Synthesebausteine II - Prenylderivate |
JP4065573B2 (ja) | 1997-04-18 | 2008-03-26 | ベーリンガー・インゲルハイム・インテルナツィオナール・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | 反応媒体として圧縮二酸化炭素中における二官能性または多官能性基質の選択的オレフィンメタセシス |
DE19821954A1 (de) | 1997-05-15 | 1998-11-19 | Biotechnolog Forschung Gmbh | Verfahren zur Herstellung eines Epothilon-Derivats |
DE19720312A1 (de) | 1997-05-15 | 1998-11-19 | Hoechst Ag | Zubereitung mit erhöhter in vivo Verträglichkeit |
DE19726627A1 (de) | 1997-06-17 | 1998-12-24 | Schering Ag | Zwischenprodukte, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von Epothilon |
US6605599B1 (en) | 1997-07-08 | 2003-08-12 | Bristol-Myers Squibb Company | Epothilone derivatives |
ES2184307T3 (es) | 1997-07-16 | 2003-04-01 | Schering Ag | Derivados de tiazol, procedimiento para su preparacion y su utilizacion. |
IL134419A0 (en) | 1997-08-09 | 2001-04-30 | Schering Ag | Epothilone derivatives, process for the preparation thereof and pharmaceutical compositions containing the same |
US6365749B1 (en) | 1997-12-04 | 2002-04-02 | Bristol-Myers Squibb Company | Process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs |
SI1052974T1 (sl) | 1998-02-05 | 2009-10-31 | Novartis Ag | Farmacevtska formulacija, ki vsebuje epotilon |
US6194181B1 (en) | 1998-02-19 | 2001-02-27 | Novartis Ag | Fermentative preparation process for and crystal forms of cytostatics |
FR2775187B1 (fr) | 1998-02-25 | 2003-02-21 | Novartis Ag | Utilisation de l'epothilone b pour la fabrication d'une preparation pharmaceutique antiproliferative et d'une composition comprenant l'epothilone b comme agent antiproliferatif in vivo |
DE69927790T2 (de) | 1998-02-25 | 2006-07-20 | Sloan-Kettering Institute For Cancer Research | Synthese von epothilonen, ihren zwischenprodukten und analogen verbindungen |
US6380395B1 (en) | 1998-04-21 | 2002-04-30 | Bristol-Myers Squibb Company | 12, 13-cyclopropane epothilone derivatives |
AU5036999A (en) | 1998-06-30 | 2000-01-17 | Schering Aktiengesellschaft | Epothilon derivatives, their preparation process, intermediate products and their pharmaceutical use |
JP4662635B2 (ja) | 1998-11-20 | 2011-03-30 | コーサン バイオサイエンシーズ, インコーポレイテッド | エポチロンおよびエポチロン誘導体を生成するための組換え方法および材料 |
AU2795000A (en) | 1998-12-22 | 2000-07-12 | Novartis Ag | Epothilone derivatives and their use as antitumor agents |
US6610736B1 (en) | 1999-02-18 | 2003-08-26 | Schering Ag | 16-Halogen-epothilone derivatives, method for producing them and their pharmaceutical use |
CZ301498B6 (cs) * | 1999-02-22 | 2010-03-24 | Gesellschaft Fuer Biotechnologische Forschung Mbh (Gbf) | C-21 modifikované epothilony |
US6211412B1 (en) | 1999-03-29 | 2001-04-03 | The University Of Kansas | Synthesis of epothilones |
PE20010116A1 (es) | 1999-04-30 | 2001-02-15 | Schering Ag | Derivados de 6-alquenil-, 6-alquinil- y 6-epoxi-epotilona, procedimientos para su preparacion |
-
2002
- 2002-02-06 KR KR10-2003-7010872A patent/KR20040028720A/ko not_active Application Discontinuation
- 2002-02-06 WO PCT/US2002/004247 patent/WO2002066033A1/en not_active Application Discontinuation
- 2002-02-06 MX MXPA03007423A patent/MXPA03007423A/es unknown
- 2002-02-06 IL IL15712802A patent/IL157128A0/xx unknown
- 2002-02-06 HU HU0400041A patent/HUP0400041A2/hu unknown
- 2002-02-06 RU RU2003128312/14A patent/RU2003128312A/ru not_active Application Discontinuation
- 2002-02-06 CA CA002438598A patent/CA2438598A1/en not_active Abandoned
- 2002-02-06 BR BR0207316-1A patent/BR0207316A/pt not_active Application Discontinuation
- 2002-02-06 JP JP2002565591A patent/JP2004522771A/ja active Pending
- 2002-02-06 EP EP02724940A patent/EP1368030A1/en not_active Withdrawn
- 2002-02-06 EE EEP200300397A patent/EE200300397A/xx unknown
- 2002-02-06 PL PL02363363A patent/PL363363A1/xx not_active Application Discontinuation
- 2002-02-06 CN CNA028052447A patent/CN1610549A/zh active Pending
- 2002-02-08 US US10/071,988 patent/US6727276B2/en not_active Expired - Fee Related
-
2003
- 2003-08-07 BG BG108072A patent/BG108072A/xx unknown
- 2003-08-12 ZA ZA200306237A patent/ZA200306237B/en unknown
- 2003-08-18 IS IS6917A patent/IS6917A/is unknown
- 2003-08-19 NO NO20033682A patent/NO20033682L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP2004522771A (ja) | 2004-07-29 |
EP1368030A1 (en) | 2003-12-10 |
RU2003128312A (ru) | 2005-02-10 |
WO2002066033A1 (en) | 2002-08-29 |
CA2438598A1 (en) | 2002-08-29 |
KR20040028720A (ko) | 2004-04-03 |
ZA200306237B (en) | 2004-12-23 |
US20020165257A1 (en) | 2002-11-07 |
US6727276B2 (en) | 2004-04-27 |
HUP0400041A2 (hu) | 2004-04-28 |
PL363363A1 (en) | 2004-11-15 |
BR0207316A (pt) | 2004-02-10 |
MXPA03007423A (es) | 2003-11-18 |
EE200300397A (et) | 2003-12-15 |
IL157128A0 (en) | 2004-02-08 |
CN1610549A (zh) | 2005-04-27 |
NO20033682L (no) | 2003-08-19 |
BG108072A (en) | 2005-04-30 |
IS6917A (is) | 2003-08-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20033682L (no) | Epothilone-derivater for behandling av refraktor-tumorer | |
EE200300396A (et) | Epotilooni derivaatide kasutamine refraktaarsete kasvajate raviks | |
NO20025792L (no) | Kinazolinderivater for behandling av tumorer | |
NO20013380L (no) | 2-aminobenzoksazinonderivater for behandling av fedme | |
NO20013369D0 (no) | Arylpiperazinyl-cykloheksyl-indol-derivater for behandling av depresjon | |
NO20034523L (no) | Pyrazolderivater for behandling av HIV | |
NO20031442L (no) | Morfolin-acetamidderivater for behandling av inflammatoriske sykdommer | |
NO20052894D0 (no) | 4-tetrazolyl-4-fenylpiperidin-derivater for behandling av smerte | |
NO20013381D0 (no) | 2-oksybenzoksazinonderivater for behandling av fedme | |
NO20032801D0 (no) | Tiazolderivater for behandling av PPAR relaterte forstyrrelser | |
NO20042680L (no) | Fremgangsmater for fremstilling av O-demetylvenflaxine | |
NO20026263L (no) | Sulfonyl-pyrrolidin-derivater anvendelige for behandling av neurologiske forstyrrelser | |
NO20040516L (no) | Kombinasjonsterapi for behandling av kreft. | |
NO20034780L (no) | Antiangiogenisk kombinasjonsterapi for behandling av kreft | |
NO20041386L (no) | Kombinasjoner for bahandling av immunoinflammatoriske forstyrrelser | |
NO20024775D0 (no) | Hydroksyfenyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte | |
PL373912A1 (en) | Heterocyclic derivatives for the treatment of cancer and other proliferative diseases | |
NO20020358D0 (no) | Anvendelse av etodolac for behandling av kreft | |
NO20034123L (no) | Fremgangsmåte for behandling av brennstoff | |
NO20024776L (no) | Hydroksyfenyl-piperazinyl-metyl-benzamid derivater til behandling av smerte | |
NO20033341D0 (no) | Metoder for administrering av epothilone-analoger for behandling av kreft | |
NO20042476L (no) | Anvendelse av desoxypeganin for behandling av klinisk depresjon | |
NO20012612L (no) | Isonipecotamider for behandlingen av integrin-formidlede sykdommer | |
NO20043113L (no) | Fremgangsmate for behandling av benforstyrrelse | |
NO20033290L (no) | Pyrrolderivater for behandling av cytokinformidlede sykdommer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |